A pricey gene therapy treatment for spinal muscular atrophy (SMA) will be available through the National Health Service in England later this year, the Guardian reports.
A pricey gene therapy treatment for spinal muscular atrophy (SMA) will be available through the National Health Service in England later this year, the Guardian reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.